Peripheral Arterial Disease Trial, Recruiting NCT07012070 Sponsor: Chinese University of Hong Kong Condition: Peripheral Arterial Disease
Back to Peripheral Arterial Disease

Peripheral Arterial Disease Trial, Recruiting

NCT07012070
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have recently been diagnosed with leg pain or cramping when walking (called claudication), identified by answering a specific question about your symptoms
  • Your ankle-arm blood pressure reading (a test that checks blood flow to your legs) shows a result below 0.9, suggesting reduced blood flow to the legs

Who may not be able to join:

  • You are unable to walk without the help of a walking aid, or are unable to follow exercise instructions
  • You have previously had a procedure or surgery to open up or bypass blocked blood vessels in your legs
  • You have a severe form of reduced blood flow to your legs, or have tissue damage or gangrene in your legs
  • You have had a major amputation of part of your leg
  • You have another health condition that makes it difficult for you to walk
  • You have an unstable heart condition, such as unstable chest pain or a recent heart attack event
  • You have been diagnosed with advanced heart failure (classified as Class III or IV) (confirm with trial site)
  • You are unable to use basic electronic devices
  • You do not have access to a mobile network signal where you live
  • You are not willing to share your personal data with the research team
  • Your life expectancy is less than 6 months

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: GuangMing Tan, Chinese University of Hong Kong

Phone: 97645701

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 June 2025
Est. completion
31 December 2027

Where this trial is recruiting

Hong Kong

Primary endpoints

Change in 6-minute walk test distance

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov